{"name":"Applied Molecular Transport","slug":"applied-molecular-transport","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":89826000,"netIncome":-126325000,"cash":61145000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AMT-126","genericName":"AMT-126","slug":"amt-126","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AMT-126","genericName":"AMT-126","slug":"amt-126","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE43b3pmdjlTaUk1WFoweDlEbDFfZDZ3b2dXSFl2WDBRa3ZWUk93cGk1a3FuZ1YxR290OExvdmhXbnRzaGZkeGpvVXRfU0tvS0N1bmI3cVhERzU1a0pW?oc=5","date":"2026-01-21","type":"pipeline","source":"EurekAlert!","summary":"When scientists build nanoscale architecture to solve textile and pharmaceutical industry challenges - EurekAlert!","headline":"When scientists build nanoscale architecture to solve textile and pharmaceutical industry challenges - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBvUmkxNnhEOHQ0S19hUTFWenFIOXJsQW9oMHJQN2QwMVM2aEoyMWNFTmdQRVdpbUJtV0NmQ0RtWWpTcjcwV19oSF80UWZ5SDhmbU1N?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"AMTI Stock Price, News & Analysis - Stock Titan","headline":"AMTI Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5KNXRqU1BTRmRLcmc0VFl1ejNyOEFrbWUyYmR3SktPdXlkWVEzYmhYMy1Fa0JidUlHaGZESFlGNGNDVldKTG1RRXlCUnMwVU5kZjViYWxOMlotQU5OWDBjUmw4LTNyZlhTZ0phZE9Xdw?oc=5","date":"2025-04-22","type":"pipeline","source":"Hunt Scanlon Media","summary":"Klein Hersh Recruits CFO for TRex Bio - Hunt Scanlon Media","headline":"Klein Hersh Recruits CFO for TRex Bio","sentiment":"neutral"},{"date":"2023-12-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVjdtanZxRTYyN3FmRDNERXBvd3M5b2IwS2FuZUtGaWtnOGI2UUdUYndqcmg2a2VKSW5jV1d3X3dKQnY5UldYOEd1SFFqLXNhVlhJQWdyeGJrM0tVMDdqZlhDME8xZU1DY0w3YkJsckhhaFVrQmw4djhZdnkzRjViYXo5T2prMV9JX2JuTURmMzlnRGE3ek1TeHlnN1JUUF83N3dIeThoX3RpdlhrRUE?oc=5","date":"2023-09-25","type":"pipeline","source":"The Business Journals","summary":"This biotech went public 3 years ago at $14 per share. Here's how its stock cratered to 27 cents - The Business Journals","headline":"This biotech went public 3 years ago at $14 per share. Here's how its stock cratered to 27 cents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYjM4WXRscG1tTjZKQ1VGWXZIRWxhVHJYajV1YU5PbkxNdU9jMVFtajVOeU10UUJIaUNldHFWWm0xdDB1aUdMN3lXVlQ5MmVGb1VvZjRUTkx2bVJyNmtVajNrRXRRUXRxaDJWRmxESnZwOVVkYjkyM1FXaDVfNi1XUWNEeVVnMXNON1pmRUlaZVpxcDViX3kwbVdrUzZuT0ZJeEE?oc=5","date":"2023-03-28","type":"pipeline","source":"Fierce Biotech","summary":"With another wave of layoffs and CEO exit, AMT seeks out 'strategic alternatives' - Fierce Biotech","headline":"With another wave of layoffs and CEO exit, AMT seeks out 'strategic alternatives'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNemRXMXdubFhLX2ktWlhUUEtMNzRaQVA3djVjbWhsSVV2RFlqT2pVUWtfZWVHRkQ1Q1JVNE1PWUJNUjY4cmg2czN6R0VabjIxZFF4RWxqeHFxeUpQYk5YcmlCQjg2cnZReDFia3pxVjIwY1pEakhEbW5oZDdQMmpfRExOWHFONDZhVDZsY3hZeGJRdmkzWnV0TmJwZ1VKVng1akpqMXRqWEVGdnV0dUE4dXpHX25WODN5YUl2YmRtcDlTOFNjbGRnQTN3cUFGM21jVmc?oc=5","date":"2022-10-24","type":"pipeline","source":"Healio","summary":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC - Healio","headline":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9rN1ZsaVBXb1dXYndwZ2tqcC1iYVR4Z0M4WHRXSmJsNGJIQmpPVWpQYll4XzhtczlPZ08wYU1VdWxkNWJsa3g3N0t6MzFkd3M1MU1mYjdjNHNtS0d3V0VCR1VKOFh4V2pWWUE?oc=5","date":"2022-09-16","type":"pipeline","source":"Wiley Online Library","summary":"Landscape of new drugs and targets in inflammatory bowel disease - Wiley Online Library","headline":"Landscape of new drugs and targets in inflammatory bowel disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWXM2YTBSWktzR3UwVE45Qi1OTFJZNVlreEJkSVd2LWpBZ2FILU9uMHJHZUM5VUlqUm9Mb3VtUkI5S3g0WkpDTTVzeWZFbzhpbTB5dzRSV3RUc1QtSDNfT0ZGNkVhbVU1VmVkdTBGa0pNLXZKU210WmlTY2tvb0tjd1JubTdUVU55WjBiUWlTTW1rdG8zdDdvMURlMmZaQldFY3phRzZwUFA3aExFc25qdkVoWHFFUFRiUEtyaXFzWHJwdw?oc=5","date":"2022-05-18","type":"pipeline","source":"Fierce Biotech","summary":"Applied Molecular Transport's co-founder exits along with 40% of staff as early pipeline activity paused - Fierce Biotech","headline":"Applied Molecular Transport's co-founder exits along with 40% of staff as early pipeline activity paused","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQSkNzSTlLSDlEUC1PVXREUGk5ZTIzaGFZVVk2YmctcUpRYWYxdEhSV21lTmIydmZ1QVdncTV1bGZ4YVFEUXQ1Zk5qck9tbDlaNE5sNUx0QXNXNUt2Z1NpQ0d2NjhzQUhzNTY2Y0NlcXRkN21QaFdGUWI2X0dxRVBGYXZXUWtsbndZb0x1XzBfXzR1TlZJdDh2bnZzTnplSmRqN19ueThfVnlFMWtVSDhOMmxDejJlUQ?oc=5","date":"2022-01-10","type":"pipeline","source":"Fierce Pharma","summary":"J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules - Fierce Pharma","headline":"J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE5vOGh5cjlNYUd6VEF6N1ZZU1U1dUt6SDdPdDdPcDdjLXQtMHJlWkJiSWhLUHdFcEJCOWh4QzZseklkRUtOMkkwTERWZ0FBdw?oc=5","date":"2020-08-23","type":"deal","source":"Stock Titan","summary":"Latest AMTI News - Cyclo Therapeutics, Inc. Completes Merger w... - Stock Titan","headline":"Latest AMTI News - Cyclo Therapeutics, Inc. Completes Merger w...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRjFqRFFFZWM3bWtjRngyRDQ5dXlJSnN4UTZoMzBnVk5Vejl3VE1WUV9KMWNqcDJpSXFJWUZlaW5zb3Q5T0xvdW9aODhLeGk5eDZ0ck1haVM5bmw5R0FCVmFrWThUTnpaTXdPTW5aX3VDX0sxbWZ3TGNHMzdlUGZpa21ERHJQcFA1UU1NanRpUTJmZHBuVXRncndTOWFWZUZqWGFOQzFuMUxhU1IwN1IxV1V3bWZmVjJtUnhWVFZMQzN5NXNrSW5nWFloWW1RdkxqU0tGQTgwQ3owcE9HZnlOQVoyODdiUnlMT1BxNg?oc=5","date":"2018-08-28","type":"pipeline","source":"European Medical Journal","summary":"Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal","headline":"Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":89826000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-126325000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":61145000,"cashHistory":[],"totalAssets":107446000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}